Baxter International Inc (BAX) stock
BAXNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 9/304% above fair value
$25.81+0.07 (+0.27%)
Close on Nov 13, 2026Market cap $13.35BP/E –Yield 2.01%
Baxter International ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Baxter International's ebitda for the twelve months ending Sep 30, 2026 was $734.00M, down 24.5% year over year. For fiscal 2025 it was $673.00M, down 33.4% from the year before. Over ten years it grew -5.7% a year on average. The highest annual figure on record is $2.56B in fiscal 2019.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $673.00M | -33.4% |
| FY2024 | Dec 31, 2024 | $1.01B | -40.2% |
| FY2023 | Dec 31, 2023 | $1.69B | – |
| FY2022 | Dec 31, 2022 | -$1.77B | -180.0% |
| FY2021 | Dec 31, 2021 | $2.22B | -9.1% |
| FY2020 | Dec 31, 2020 | $2.44B | -4.8% |
| FY2019 | Dec 31, 2019 | $2.56B | +8.7% |
| FY2018 | Dec 31, 2018 | $2.36B | +15.6% |
| FY2017 | Dec 31, 2017 | $2.04B | +31.9% |
| FY2016 | Dec 31, 2016 | $1.55B | +27.9% |
| FY2015 | Dec 31, 2015 | $1.21B | -16.6% |
| FY2014 | Dec 31, 2014 | $1.45B | +28.0% |
| FY2013 | Dec 31, 2013 | $1.13B | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $464.00M | +13.4% |
| Q2 FY2026 | Jun 30, 2026 | $456.00M | +1.8% |
| Q1 FY2026 | Mar 31, 2026 | $303.00M | -0.7% |
| Q4 FY2025 | Dec 31, 2025 | -$489.00M | – |
| Q3 FY2025 | Sep 30, 2025 | $409.00M | 0.0% |
| Q2 FY2025 | Jun 30, 2025 | $448.00M | +10.3% |
| Q1 FY2025 | Mar 31, 2025 | $305.00M | -21.0% |
| Q4 FY2024 | Dec 31, 2024 | -$190.00M | -133.5% |
| Q3 FY2024 | Sep 30, 2024 | $409.00M | +50.9% |
| Q2 FY2024 | Jun 30, 2024 | $406.00M | +36.2% |
| Q1 FY2024 | Mar 31, 2024 | $386.00M | -12.7% |
| Q4 FY2023 | Dec 31, 2023 | $568.00M | – |
| Q3 FY2023 | Sep 30, 2023 | $271.00M | – |
| Q2 FY2023 | Jun 30, 2023 | $298.00M | -50.9% |
| Q1 FY2023 | Mar 31, 2023 | $442.00M | -18.6% |
| Q4 FY2022 | Dec 31, 2022 | -$294.00M | -220.0% |
| Q3 FY2022 | Sep 30, 2022 | -$2.55B | -454.5% |
| Q2 FY2022 | Jun 30, 2022 | $607.00M | -6.0% |
| Q1 FY2022 | Mar 31, 2022 | $543.00M | -10.5% |
| Q4 FY2021 | Dec 31, 2021 | $245.00M | -60.4% |
| Q3 FY2021 | Sep 30, 2021 | $719.00M | +5.9% |
| Q2 FY2021 | Jun 30, 2021 | $646.00M | +21.2% |
| Q1 FY2021 | Mar 31, 2021 | $607.00M | -0.2% |
| Q4 FY2020 | Dec 31, 2020 | $619.00M | -16.9% |
| Q3 FY2020 | Sep 30, 2020 | $679.00M | -2.7% |
| Q2 FY2020 | Jun 30, 2020 | $533.00M | -1.8% |
| Q1 FY2020 | Mar 31, 2020 | $608.00M | +5.7% |
| Q4 FY2019 | Dec 31, 2019 | $745.00M | +29.3% |
| Q3 FY2019 | Sep 30, 2019 | $698.00M | +19.1% |
| Q2 FY2019 | Jun 30, 2019 | $543.00M | -4.6% |
| Q1 FY2019 | Mar 31, 2019 | $575.00M | -7.9% |
| Q4 FY2018 | Dec 31, 2018 | $576.00M | +21.0% |
| Q3 FY2018 | Sep 30, 2018 | $586.00M | +21.1% |
| Q2 FY2018 | Jun 30, 2018 | $569.00M | +7.2% |
| Q1 FY2018 | Mar 31, 2018 | $624.00M | +14.1% |
| Q4 FY2017 | Dec 31, 2017 | $476.00M | -5.6% |
| Q3 FY2017 | Sep 30, 2017 | $484.00M | – |
| Q2 FY2017 | Jun 30, 2017 | $531.00M | – |
| Q1 FY2017 | Mar 31, 2017 | $547.00M | – |
| Q4 FY2016 | Dec 31, 2016 | $504.00M | – |
See a number that looks wrong?